FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Lyvispahbaclofen | Baclofen 10 mg/1 | GranuleOral | Anvi Pharmaceuticals Inc | Sep 1, 2026 | 87519-003 |
| Imiquimod | Imiquimod 37.5 mg/g | CreamTopical | Anvi Pharmaceuticals Inc. | Sep 1, 2026 | 87519-004 |
| Clomiphene Citrate | Clomiphene citrate 50 mg/1 | TabletOral | Camber Pharmaceuticals Inc | Aug 31, 2026 | 31722-541 |
| Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral | Sodium sulfate 17.5 g/177mL + 2 more ingredients | SolutionOral | Macleods Pharmaceuticals Limited | Aug 31, 2026 | 33342-546 |
| pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc. | Aug 31, 2026 | 43598-517 |
| pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc. | Aug 31, 2026 | 43598-518 |
| pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc. | Aug 31, 2026 | 43598-519 |
| pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc. | Aug 31, 2026 | 43598-520 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Coupler LLC | Aug 31, 2026 | 67046-0340 |
| Hydroxyzine hydrochloride | Hydroxyzine hydrochloride 50 mg/1 | TabletOral | Coupler LLC | Aug 31, 2026 | 67046-0566 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2.5 mg/1 | TabletOral | Coupler LLC | Aug 31, 2026 | 67046-1145 |
| Decitabine | Decitabine 50 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | BluePoint Laboratories | Aug 31, 2026 | 68001-713 |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | Aug 31, 2026 | 70095-057 |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | Aug 31, 2026 | 70095-058 |
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | Aug 31, 2026 | 70095-059 |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | Sun Pharmaceutical Industries, Inc. | Aug 31, 2026 | 70095-060 |
| Ibuprofen | Ibuprofen 600 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | Aug 31, 2026 | 70518-4741 |
| Ferric Carboxymaltose | Ferric carboxymaltose 50 mg/mL | Injection, SolutionIntravenous | Mylan Institutional LLC | Aug 31, 2026 | 72078-048 |
| Beqalzisonrotoclax | — | Kit | BeOne Medicines USA, Inc. | Aug 31, 2026 | 72579-015 |
| Beqalzisonrotoclax | Sonrotoclax 5 mg/1 | Tablet, Film coatedOral | BeOne Medicines USA, Inc. | Aug 31, 2026 | 72579-017 |
| Beqalzisonrotoclax | Sonrotoclax 1 mg/1 | Tablet, Film coatedOral | BeOne Medicines USA, Inc. | Aug 31, 2026 | 72579-020 |
| Beqalzisonrotoclax | Sonrotoclax 80 mg/1 | Tablet, Film coatedOral | BeOne Medicines USA, Inc. | Aug 31, 2026 | 72579-022 |
| Beqalzisonrotoclax | Sonrotoclax 20 mg/1 | Tablet, Film coatedOral | BeOne Medicines USA, Inc. | Aug 31, 2026 | 72579-025 |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | Cipla USA Inc. | Aug 30, 2026 | 69097-036 |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | Cipla USA Inc. | Aug 30, 2026 | 69097-037 |